Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

NCT05327686 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

240

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Renal Cell Carcinoma
Stage III Renal Cell Cancer AJCC v8
Stage IV Renal Cell Cancer AJCC v8
Unresectable Renal Cell Carcinoma

Interventions

BIOLOGICAL: Avelumab
DRUG: Axitinib
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Scan
DRUG: Cabozantinib
PROCEDURE: Computed Tomography
BIOLOGICAL: Ipilimumab
DRUG: Lenvatinib
PROCEDURE: Magnetic Resonance Imaging
BIOLOGICAL: Nivolumab
BIOLOGICAL: Pembrolizumab
RADIATION: Stereotactic Ablative Radiotherapy

Sponsor

NRG Oncology

Collaborators

[object Object]